AMLX
#1549
Amylyx Pharmaceuticals, Inc. - Common Stock
33.3 5 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.00%
Changement Mensuel
+64.37%
Evolution sur 6 mois
+122.33%
Changement Annuel
+262.50%
Clôture Précédente
34.7 4
Open
33.4 2
Low
33.3 1
High
33.6 5
Volume
544
Financials
- Market Capitalization 3.72 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.74
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1526 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.71 USD | -1.00% | -1.15% | +11.95% | +21.88% | 3.83 B USD | ||
| 1539 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.09 USD | -1.77% | -4.97% | +8.73% | +75.75% | 3.76 B USD | ||
| 1554 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.66 USD | -1.42% | -0.96% | +3.54% | +46.32% | 3.78 B USD | ||
| 1556 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.40 USD | +0.75% | -1.73% | +1.92% | +20.13% | 3.78 B USD |